Single-cell analysis of AD brains will reveal a distinct astrocyte subpopulation characterized by upregulated xanthine oxidoreductase (XOR), hexokinase 2 (HK2), and aldehyde dehydrogenase 2 (ALDH2) expression, representing a metabolic reprogramming toward purine metabolism and oxidative stress response. This 'stress-responsive astrocyte' (SRA) state differs from canonical disease-associated astrocytes (DAAs) and is preferentially enriched in regions with high tau burden (entorhinal cortex, hippocampus) compared to regions with lower neurofibrillary tangle density (prefrontal cortex, cerebellum). SRA cells exhibit transcriptional signatures of impaired ammonia clearance and lactate accumulation, contributing to extracellular metabolic dysfunction. The SRA transcriptional program is driven by NRF2-mediated oxidative stress response and predicts cognitive decline severity independent of amyloid burden, suggesting a mechanistic link between astrocyte metabolic dysfunction and tau-mediated neurodegeneration.
Curated pathway from expert analysis
flowchart TD
A["XOR Expression<br/>Xanthine Oxidoreductase"]
B["Purine Metabolism<br/>Reactive Oxygen Species"]
C["NRF2-Mediated<br/>Oxidative Stress Response"]
D["Astrocyte<br/>Oxidative State"]
E["Regional Vulnerability<br/>AD-Associated State"]
F["XOR as<br/>Oxidative Stress Target"]
A --> B
B --> C
C --> D
D --> E
E --> F
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for XOR yet. Search RCSB →
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for XOR.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF we perform single-nucleus RNA sequencing on postmortem entorhinal cortex and hippocampus tissue from AD patients with high Braak stage tau pathology compared to prefrontal cortex and cerebellum tis | XOR+ astrocytes co-expressing HK2 and ALDH2 will be enriched in entorhinal cortex and hippocampus compared to prefrontal cortex and cerebellum in AD brains | — no observation — | pending | 0.70 |
| IF we regress cognitive decline trajectories (measured by annualized change in MMSE or CDR-SB) against the proportion of XOR+ SRA cells in prefrontal cortex transcriptomes while controlling for amyloi | XOR+ SRA astrocyte proportion will independently predict cognitive decline severity after accounting for amyloid burden | — no observation — | pending | 0.65 |